Yüklüyor......
Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry
OBJECTIVE: Cholinesterase inhibitors (ChEIs) and memantine are the only approved pharmacological treatments for Alzheimer’s disease (AD). Recent literature suggests reductions in cardiovascular burden and risk of stroke in ChEI users. However, the clinical effectiveness of these drugs in patients wi...
Kaydedildi:
| Yayımlandı: | BMJ Open Diabetes Res Care |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039592/ https://ncbi.nlm.nih.gov/pubmed/31958305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000833 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|